X8W-20794-75552
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 571 / SD
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 1 — Pfizer-BioNTech
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
-
2021-05-07
Dose 2 — Pfizer-BioNTech
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-08-06
- 2021-11-05
-
2021-11-10
Dose 3 — Pfizer-BioNTech
-
2021-11-12
Survey response — days 1–6 daily, dose 3MedDRA: Night sweats — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painFree text: Night sweatsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-24
-
2022-02-09
Survey response — 3 months, dose 3MedDRA: Chills, Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested twice for covid due to symptoms sore throat, headache, fatigue, chills. Negative both times.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-11
-
2022-11-10
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Night sweats
Release 11 — 3 months, dose 3
Symptoms: Tested twice for covid due to symptoms sore throat, headache, fatigue, chills. Negative both times.
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Night sweats | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release